AAOS Management of Glenohumeral Joint Osteoarthritis Evidence-Based Clinical Practice Guideline
- MeSH Terms
- Shoulder Joint (A02.835.583.748); Musculoskeletal Diseases (C05); Musculoskeletal System (A02); Osteoarthritis (C05.550.114.606); Rehabilitation (E02.831)
- Guideline Contact
- Barbara Krause (krause@aaos.org)
- Keywords
- Hyaluronic acid, Prognostic factors, total shoulder arthroplasty, glenoid component, metal backed cement less glenoid component, subscapularis peel, lesser tuberosity osteotomy, tenotomy, hemiarthroplasty stems, injectable biologics, CAMS: acupuncture, dry needling, cannabis, CBD oil, non-prescription pain patches, capsaicin, shark cartilage, glucosamine and chondroitin, cupping, cemented stems, anatomic or reverse total shoulder arthroplasty, polyethylene-metal or all polyethylene glenoid components, bicep tenodesis and tenotomy, tranexamic acid, supraspinatus tears,
- Publication Date
- 03/23/2020
- Date of Last Evidence Search
- 06/07/2019
- Methods Applied
- GRADE
- Publication Scope
- management
- prognosis
- rehabilitation
- treatment
- Countries of Application
- United States
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- AAOS (USA)
- Publication Year
- 2020